CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer
Authors
Keywords
ovarian cancer; Ribociclib; CDK 4/6 inhibitor; chemotherapy resistance; cell cycle
Journal
Oncotarget
Volume 9, Issue 21, Pages -
Publisher
Impact Journals, LLC
Online
2018-02-27
DOI
10.18632/oncotarget.24585

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.